APCR Issues Statement on COVID-19

Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research

News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971

Fears Of Recession Mount As Coronavirus Declared A Pandemic

Thu, 03/12/2020 - 2:10am

Investor sentiment still backing growth for pharma and biotech sectors, but the length and severity of COVID-19's impact globally has...

      Related Stories 

Zydus Cadila Joins IO Therapy League With XOMA Tie-up

Thu, 03/12/2020 - 12:05am

Cadila Healthcare has entered the immuno-oncology race by inking a licensing agreement with US-based XOMA for a drug candidate that...

      Related Stories 

Silverback Raises $78.5m To Test Localized Therapy Delivered Systemically In Patients

Wed, 03/11/2020 - 9:36am

The company will initiate a clinical trial this year for lead ADC candidate SBT6050, which links a HER2-targeting antibody to...

      Related Stories 

Sanofi To Test Arthritis Drug Kevzara For Coronavirus

Wed, 03/11/2020 - 8:21am

The French giant is already working on a vaccine to combat COVID-19 and is now evaluating whether its rheumatoid arthritis...

      Related Stories 

Gilead's China Remdesivir Patents Confirmed, Generics Firms Cautioned

Wed, 03/11/2020 - 12:10am

As the front-runner antiviral in the fight against the coronavirus gets increasingly positive attention in China, officials take action to...

      Related Stories 

Beyond Aducanumab: Neurimmune Advances Portfolio Of Clinical Candidates

Tue, 03/10/2020 - 10:02am

The Swiss firm that discovered Biogen’s Alzheimer’s therapy aducanumab has built a pipeline of clinical programs across neurological and other...

      Related Stories 

Italy's Coronavirus Lockdown: Industry Moves To Head Off Drug Shortages In Europe

Tue, 03/10/2020 - 8:54am

As Italy extends its lockdown to its entire 60 million population, industry leaders are confident co-ordination will head off medicines...

      Related Stories 

Pipeline Watch: Approvals For Sarclisa, Durysta

Tue, 03/10/2020 - 7:29am

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies...

      Related Stories 

Sanofi's Dupixent To Keep Soaring Despite NICE Blip

Tue, 03/10/2020 - 6:45am

NICE is not recommending Dupixent for severe asthma just yet but Sanofi remains confident of hitting its sales target of...

      Related Stories 

In A Volatile Time, Pharma Reassures Business Remains Steady

Mon, 03/09/2020 - 2:00pm

Amid a stock market freefall spurred largely by coronavirus uncertainty, big pharma sought to reassure investors and the public that...

      Related Stories 

Kala’s Third Phase III Trial Should Line Up Approval In Dry Eye

Mon, 03/09/2020 - 1:10pm

Data showing that endpoints were met for both signs and symptoms of dry eye disease should position Kala’s KRI-121 for...

      Related Stories 

Publisher’s Spotlight: Shortlist Announced For The Citeline Awards

Mon, 03/09/2020 - 7:16am

The finalists have been announced for the fifth annual awards, formerly known as the Clinical Research and Excellence (CARE) Awards...

      Related Stories 

Stockwatch: Is Alnylam’s Rare Disease Business Model Sustainable?

Mon, 03/09/2020 - 5:34am

Alnylam’s fourth-quarter and full-year 2019 earnings announcement was only one of eight announcements made by the company since early February...

      Related Stories